logo
Franklin Templeton Plans to Convert 10 Putnam Municipal Bond Mutual Funds into ETFs

Franklin Templeton Plans to Convert 10 Putnam Municipal Bond Mutual Funds into ETFs

Yahoo20-05-2025
Franklin Templeton has revealed plans to convert 10 of its Putnam municipal bond mutual funds into exchange-traded funds (ETFs), a move that significantly broadens its municipal bond ETF offerings. This development follows Franklin Resources, Inc. (NYSE:BEN) acquisition of Putnam Investments in January 2024. The transition is slated to take place between the fourth quarter of 2025 and the first quarter of 2026.
Franklin Resources, Inc. (NYSE:BEN) is a global investment management firm that serves clients in more than 150 countries through its network of subsidiaries.
Patrick O'Connor, who leads Global ETFs at Franklin Resources, Inc. (NYSE:BEN), indicated that the decision to convert the funds into ETFs was aimed at addressing investor demand for high-quality municipal bond strategies in a more cost-effective, flexible, and transparent format. He noted that the firm's ETF offerings are designed to provide a broad range of options for all types of investors. According to him, the planned additions demonstrate the company's ongoing commitment to this goal and represent a significant step forward as active fixed-income strategies continue to evolve within the ETF landscape.
Franklin Resources, Inc. (NYSE:BEN) introduced its first ETF in 2014, aiming to offer investors access to its investment expertise through a low-cost and transparent structure. Since then, the firm has steadily grown its ETF offerings worldwide, now covering active, passive, and smart beta strategies. As of May 15, 2025, its U.S. ETF platform features more than 70 funds, managing roughly $32 billion in assets. The planned changes to its product lineup are expected to further solidify the company's standing as a leading provider of diverse ETF options across all strategy types.
The firm also emphasized the ongoing importance of municipal bonds in investor portfolios, noting their appeal due to federally tax-exempt income, historically low default rates, and their role as effective diversifiers within fixed-income allocations. BEN is up by over 10% in 2025 so far.
While we acknowledge the potential of BEN to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BEN and that has 100x upside potential, check out our report about this cheapest AI stock.
READ MORE: and
Disclosure. None.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

State OK's premiums for six health plans but sends two back to drawing board
State OK's premiums for six health plans but sends two back to drawing board

Boston Globe

time4 minutes ago

  • Boston Globe

State OK's premiums for six health plans but sends two back to drawing board

Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up A logo sign outside of the headquarters of Sarepta Therapeutics, Inc, in Cambridge. TRIPPLAAR KRISTOFFER/SIPA/Sipa USA via AP Advertisement BIOTECH Amid 'unwinnable' FDA fight, analyst cuts estimate of Sarepta shares to $0 Shares of Sarepta Therapeutics Inc. have zero value following the recent back-and-forth between the drugmaker and US regulators that could lead to a market withdrawal of its Elevidys treatment, according to analysts at HC Wainwright & Co. LLC. Analysts led by Mitchell S. Kapoor on Monday slashed their price target on the stock to $0 — a rare move — from $10, while maintaining a sell recommendation. The cut comes as the drugmaker refused to voluntarily pause shipments of its lead therapy following a request by the US Food and Drug Administration after three deaths were linked to the company's gene therapies. 'We view this battle with the gatekeeper US regulatory agency as unwinnable,' Kapoor wrote in a note to clients. 'Since the request for voluntary action was likely a courtesy, we expect the FDA to ultimately require removal of Elevidys from the market.' Kapoor added that 'in the absence of future Elevidys revenues, we see no intrinsic value left in SRPT shares.' Representatives of Sarepta did not immediately respond to a Bloomberg News request for comment. Sarepta's issues with the FDA stem from reports of three patient deaths following the use of its gene therapies. Two teenage boys died of acute liver failure in recent months after taking Elevidys for the treatment of Duchenne muscular dystrophy, a muscle-wasting disease. Last week, the company said that a 51-year-old patient died of acute liver failure in June in an early-stage trial of a gene therapy to treat limb-girdle muscular dystrophy. The FDA on Friday said it placed a hold on gene therapy clinical trials for that specific muscle disease. — BLOOMBERG NEWS Advertisement FINANCE Not just checking and savings but investment accounts are boosting cash in Americans' hands New research finds that more Americans are shifting their money from checking and savings accounts into financial vehicles that pay an investment income — a trend that helps to explain the resilience of the US economy after a bout of Advertisement A container ship at the Port of Oakland in Oakland, Calif. Ben Margot/Associated Press ECONOMY Key gauge of shipping slows for second straight month The number of shipping containers carrying imports to the United States fell for a second straight month, a private gauge showed, putting the economic indicator on course for one of the sharpest year-on-year reversals on record as President Trump's tariffs disrupt purchases of goods from abroad. Inbound container volume fell 7.9 percent in June from a year before, after a 6.6 percent drop in May, veteran industry analyst John McCown wrote in a monthly report Sunday based on the 10 largest US ports. The declines more than wiped out a nearly 10 percent increase tied to inventory front-loading in April, and left the second quarter down 1.8 percent from a year earlier. 'The downward turn in 2025 will be due to tariffs and unfortunately there is nothing at present that suggests it will be short-lived,' McCown wrote. McCown said he was only aware of two periods of annual volume declines — during the global financial crisis and the pandemic — and both were short-term slumps. He estimated that a 25 percent reduction in US container volumes is 'readily possible' and would translate 'directly into a $510 billion reduction in annual commerce for the US.' The total value of goods in containers moving through US ports last year was $2.2 trillion, according to McCown's data. — BLOOMBERG NEWS Advertisement FEDERAL BUDGET CBO projects 'Big Beautiful Bill' will boost deficits by $3.4 trillion President Trump's recently enacted tax and spending law will add $3.4 trillion to US deficits over a decade and leave millions without health care coverage, according to a new estimate from the nonpartisan Congressional Budget Office. The CBO score for the law, released Monday, reflects a $4.5 trillion decrease in revenues and a $1.1 trillion decline in spending through 2034, relative to a current-law baseline. The new analysis doesn't incorporate so-called dynamic effects, such as the impact on growth or interest rates over time that the legislation's measures might have. Trump signed the 'One Big Beautiful Bill' into law on July 4 after months of negotiations with congressional Republicans. Encompassing much of Trump's economic agenda, it permanently extends his 2017 income-tax cuts and some breaks for businesses, lifts the cap on federal deductions for state and local taxes, and eliminates taxes on tips and overtime on a temporary basis, among other provisions. Passage of the law triggered warnings from some economists and investors about a widening of America's budget shortfall — already large by historical standards — that could push borrowing costs and inflation up. The Trump administration points to record collections from the tariffs he's imposed on most US imports this year, saying that revenue will help fill the gap. A number of spending cuts were included in the tax law in an effort to reduce deficits and offset the cost, including to Medicaid, which provides health insurance for low-income people. — BLOOMBERG NEWS Advertisement

Asbury Automotive Group Completes Acquisition of Herb Chambers Dealerships
Asbury Automotive Group Completes Acquisition of Herb Chambers Dealerships

Business Wire

time4 minutes ago

  • Business Wire

Asbury Automotive Group Completes Acquisition of Herb Chambers Dealerships

DULUTH, Ga.--(BUSINESS WIRE)--Asbury Automotive Group, Inc. (NYSE: ABG) (the 'Company'), one of the largest automotive retail and service companies in the U.S., has completed the acquisition of The Herb Chambers Companies (HCC), the sixteenth largest by revenue privately-owned dealership group in the country. 'We're thrilled to complete the acquisition of The Herb Chambers Companies' assets and operations,' said David Hult, Asbury's President & CEO. 'Herb redefined the car-buying experience in New England, making 'Herb Chambers' a household name, synonymous with reliability and service. The HCC team is well known for its guest-centric focus and community involvement, and we are proud to welcome the team to the Asbury family.' 'Over the past decade, I have been approached by several companies interested in acquiring my organization. Throughout it all, the opportunity and well-being of the Chambers team remained my top priority. Without question, Asbury stood out as the ideal steward. Their leadership – especially under David Hult – is, without a doubt, the best in the industry,' said Herb Chambers, founder of The Herb Chambers Companies. This acquisition further diversifies Asbury's geographic mix with entry into the Northeastern United States. The purchase of this flagship New England Region company is one of the most sizable in U.S. automotive retail history, representing $3.2 billion in revenue in 2024, and includes 33 dealerships, 52 franchises, and three collision centers. The Herb Chambers Companies sold approximately 50,000 new and used vehicles during the year ended December 31, 2024. The aggregate net purchase price was $1.45 billion, which includes $750 million for goodwill, approximately $610 million for the real estate and leasehold improvements, and approximately $85 million for new vehicles, used vehicles, service loaner vehicles, fixed assets, parts and supplies, which is net of non-manufacturer floorplan of $375 million. Asbury primarily funded the acquisition with a combination of credit facility capacity, mortgage proceeds and cash. For additional information, please see the Form 8-K that will be filed in connection with this transaction. Advisors Jones Day and Hill Ward Henderson served as legal counsel, Baker Tilly served as the transaction advisory firm, and BofA Securities served as financial advisor to Asbury; Wells Fargo served as lead for the syndicated mortgage facility. Stephens Inc. served as financial advisor and Simpson Thacher and WilmerHale served as legal counsel to HCC. About The Herb Chambers Companies Founded in 1985, The Herb Chambers Companies is one of the nation's largest private auto dealership groups and one of the leading automotive retailers in the New England region. HCC employs more than 2,200 people in locations throughout Massachusetts and Rhode Island, with most of its dealerships located in and around Boston. Herb Chambers is consistently named as one of the Boston Globe's "Top Places to Work." About Asbury Automotive Group, Inc Asbury Automotive Group, Inc. (NYSE: ABG), a Fortune 500 company headquartered in Duluth, GA, is one of the largest automotive retailers in the U.S. In late 2020, Asbury embarked on a multi-year plan to increase revenue and profitability strategically through organic operations, acquisitive growth and innovative technologies, with its guest-centric approach as Asbury's constant North Star. As of June 30, 2025, Asbury operated 145 new vehicle dealerships, consisting of 189 franchises and representing 31 domestic and foreign brands of vehicles. Asbury also operates Total Care Auto, Powered by Landcar, a leading provider of service contracts and other vehicle protection products, and 37 collision repair centers. Asbury offers an extensive range of automotive products and services, including new and used vehicles; parts and service, which includes vehicle repair and maintenance services, replacement parts and collision repair services; and finance and insurance products, including arranging vehicle financing through third parties and aftermarket products, such as extended service contracts, guaranteed asset protection debt cancellation, and prepaid maintenance. Asbury is recognized as one of America's Fastest Growing Companies 2024 by the Financial Times and the Company is listed in World's Most Trustworthy Companies 2024 by Newsweek. For additional information, visit Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements other than historical fact, and may include statements relating to goals, plans, objectives, beliefs, expectations and assumptions regarding the expected benefits of the recently completed acquisition of the Herb Chambers dealerships and performance, integration plans and expected synergies from the acquisition. The following are some but not all of the factors that could cause actual results or events to differ materially from those anticipated, including: risks related to our failure to realize the benefits expected from the acquisition; failure to promptly and effectively integrate the acquisition; disruption of management time from ongoing business operations due to the integration activities related to the acquisition; identification and remediation of insufficient control activities of the acquired business; the effect of the acquisition on the ability of Asbury to retain and hire key personnel and maintain relationships with suppliers; our ability to execute our business strategy; and other risks described from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 26, 2025 and subsequent filings. These forward-looking statements and such risks, uncertainties and other factors speak only as of the date of this press release. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

NRG Energy, Inc. to Report Second Quarter 2025 Financial Results on August 6, 2025
NRG Energy, Inc. to Report Second Quarter 2025 Financial Results on August 6, 2025

Business Wire

time4 minutes ago

  • Business Wire

NRG Energy, Inc. to Report Second Quarter 2025 Financial Results on August 6, 2025

HOUSTON--(BUSINESS WIRE)--NRG Energy, Inc. (NYSE:NRG) plans to report its second quarter 2025 financial results on Wednesday, August 6, 2025. Management will present the results during a conference call and webcast at 9:00 a.m. EST (8:00 a.m. CST). The company will issue a press release regarding the second quarter 2025 financial results prior to the conference call, and it will be available on the NRG website at The live webcast and presentation materials can be accessed at by clicking the 'presentations and webcasts' link. A replay of the webcast will be available on the site for those unable to listen in real time. About NRG NRG Energy, Inc. is leading the future of energy—now. Our solutions power a smarter, brighter future by helping customers achieve today's goals while solving for the challenges of tomorrow. Every day, we deliver innovative natural gas, electricity, and smart home solutions to customers large and small across North America. Visit for more information, and connect with us on Facebook, Instagram, LinkedIn, and X.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store